Cures Within Reach

Trials have the potential to fast-track treatment options for patients with limited therapeutic alternatives

Trials have the potential to fast-track treatment options for patients with limited therapeutic alternatives

Cures Within Reach will fund 16 additional clinical trials in next two years

Cures Within Reach will select two more veterans' focused clinical trials later in 2024

Cures Within Reach also announces its latest success story and a multi-year grant from Open Philanthropy focused on LMICs

Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors to fund these pivotal trials

These Diversity, Equity & Inclusion trials funded by Cures Within Reach often include support from community-based organizations

Clinical Repurposing Trials in Bladder Cancer and Seizures after Cardiac Arrest Receive Funding

Cures Within Reach's Virtual Pitch Event on October 6 Features Four Clinical Repurposing Trials

David C. Fajgenbaum, MD, MBA, MSc of Penn Medicine / CDRC and Incyte to be honored in 2022